Hillhouse Investment Group

Hillhouse Investment Group, established in 2005 and headquartered in Hong Kong, is a prominent global investment management firm that focuses on private equity. The firm engages in long-term investments across various sectors, including healthcare, business services, consumer goods, industrials, and energy transition. Hillhouse partners with exceptional entrepreneurs to foster sustainable value creation within quality companies. In addition to private equity, the firm also participates in public equity, real estate, and private credit, managing capital on behalf of global institutions such as non-profit foundations, endowments, and pension funds.

Huang Liming

Partner

David Rhee

Partner

Michael Yi

Partner

Sean Carney

Partner and Co-Head of Global Buyout

Past deals in Asia

Xiaohongshu

Secondary Market in 2024
Xiaohongshu, founded in 2013 and based in Shanghai, is a lifestyle sharing platform that facilitates the exchange of experiences through text, images, and videos. Initially created to assist overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle topics, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform allows users to post their favorite products, share shopping experiences, and discover global merchandise, particularly in the luxury and fashion sectors. It serves as both a social network and a social e-commerce platform, enabling users to review and purchase products from abroad.

Astronergy

Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.

Core Medical Technology

Series C in 2022
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

ZCOOL

Series C in 2022
ZCOOL is an online community platform founded in August 2006 in Beijing, designed for designers to showcase their graphic designs and connect with potential commercial opportunities. With over four million users and approximately 20,000 design works uploaded daily, the platform facilitates the sharing and display of creative work. ZCOOL collaborates with Shutterstock to enhance its image database services, further enriching the offerings for its users. The company aims to leverage recent funding to expand its community, strengthen content, and provide additional services, including training courses and job matching to support its members in their professional development.

CenoBots (Cenozoic Robotics)

Series A in 2022
Cenozoic Robotics is a global leading provider for the cleaning industry. Founded in 2021, Cenozoic Robotics is headquartered in Singapore with offices in Hong Kong and Hangzhou. Employing knowledge and experience in L4 autonomous driving technology, the Cenozoic team realized the potential to provide customers with faster service and higher quality products than currently on the world market. With this goal in mind, Michael Wang, the founder and the CEO of Cenozoic Robotics, and his team established the company and entered the cleaning industry dedicated to renewing cleaning services with state-of-the-art technologies. Up to now, Cenozoic robots have been deployed at multiple sites in Singapore, Japan, and South Korea.

Gritworld

Series B in 2022
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

EPiCMEMS

Series A in 2022
EPiCMEMS, a local chip company based in Xiamen, specializes in the development of RF front-end solutions, focusing on 4G+ and 5G RF filters and chips. The company aims to advance the domestic chip industry by producing high-speed, high-quality 5G chips tailored for mobile devices and the Internet of Things (IoT). With operational facilities in Xiamen and Zhangjiang, along with sales and customer support centers in Shenzhen, Xi'an, and Beijing, EPiCMEMS is committed to enhancing connectivity and stability for users across the mobile and IoT sectors.

XVERSE

Series A in 2022
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.

SceneRay

Series D in 2022
SceneRay Co. Ltd, based in Singapore Industrial Park, Suzhou, China, specializes in the design, development, and distribution of neuromodulation devices, particularly focusing on brain pacemakers. The company’s core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. SceneRay's product offerings include a dual-channel implantable pulse generator kit designed for deep brain stimulation, which provides therapeutic electric stimulation to address issues related to brain damage. Committed to innovation, SceneRay holds numerous patents and strives to deliver high-quality, effective treatments for patients.

Harmay

Series D in 2022
Harmay is a retailer based in China that specializes in premium cosmetics and beauty products. The company focuses on contemporary fashion and aesthetics, aiming to convey the concept of beauty and an enriched lifestyle. Harmay offers a diverse range of well-known international cosmetics and skincare brands, alongside its own self-developed personal skincare products. By targeting urban dwellers, Harmay provides high-quality makeup and cosmetics that resonate with modern beauty standards.

Westlake Omics

Seed Round in 2022
Westlake Omics is a biotechnology company based in Hangzhou, Zhejiang, China, founded in 2020. It specializes in mass spectrometry-based proteomics and other Omics technologies to meet critical clinical needs. The company aims to advance precision medicine and drug research and development by utilizing artificial intelligence for high-throughput proteomic analysis of small clinical specimens. Through its innovative approach, Westlake Omics focuses on enhancing the accuracy of tumor diagnosis and developing reliable, cutting-edge products that address significant health challenges. By integrating technological advancements and multi-modal big data, the company is dedicated to making meaningful contributions to the field of clinical diagnostics.

UWinTech

Series C in 2022
UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.

Thousand Oaks Biopharmaceuticals

Venture Round in 2021
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and located in Haimen, China, specializes in contract development and manufacturing services tailored for the biotechnology sector. The company focuses on developing biopharmaceutical technologies aimed at producing protein and vaccine compounds. It offers integrated control solutions that enhance production processes by optimizing protein expression and reducing production scale. This enables biopharmaceutical companies to access personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services. By providing these comprehensive services, Thousand Oaks Biopharmaceuticals aims to facilitate the creation of accessible and affordable biologics to meet global healthcare needs.

NASN Automotive Electronics

Series C in 2021
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company offers a range of products, including the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. By focusing on research and development, production, and sales, NASN aims to provide advanced and comprehensive solutions that enhance vehicle safety and intelligence, catering to the growing demand for innovative automotive technologies in China.

Great Bay Bio

Series A in 2021
Great Bay Bio Ltd. is a biotechnology company based in Central Hong Kong, founded in 2002. The company specializes in drug discovery and contract research services, leveraging artificial intelligence within its Chemistry, Manufacturing, and Control (CMC) platform to enhance drug development processes. Great Bay Bio is involved in the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. With a focus on biopharmaceutical innovation, the company utilizes a digital platform that integrates AI technology, big data, and Internet of Things technology to streamline the drug development cycle and reduce costs. By aligning with national strategies for scientific innovation and fostering collaboration across regions such as Europe, the United States, Singapore, and Hong Kong, Great Bay Bio aims to enhance its competitive edge in the biopharmaceutical industry.

Gritworld

Series B in 2021
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

Js Designs

Series A in 2021
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources, one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed.

Js Designs

Series B in 2021
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources, one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed.

HeyTea

Series D in 2021
HeyTea is a Chinese tea shop that specializes in cheese-topped tea and fruit tea. In 2012, HEYTEA originated from an alley in the riverside. Originally known as ROYALTEA , the royal tea was completely upgraded to the registered brand HEYTEA.

GRIT Biotechnology

Series A in 2021
GRIT Biotechnology is a research and development company based in Shanghai, China, focusing on tumor infiltration lymphocytes (TIL) immunotherapy for the treatment of solid tumors. Founded in 2019, the company is dedicated to advancing the field of immunotherapy with the aim of enhancing the effectiveness of tumor treatments. By leveraging innovative approaches in TIL technology, GRIT Biotechnology seeks to provide new therapeutic options for patients battling solid tumors.

Market Kurly

Series F in 2021
Market Kurly is an online grocery service based in Seoul, South Korea, that specializes in the delivery of fresh and premium food products. Founded in 2014, the platform allows users to order a wide range of items, including vegetables, fruits, meats, dairy, baked goods, and processed foods, all sourced directly from producers. Market Kurly focuses on providing high-quality ingredients and offers next-day delivery, ensuring that customers receive their orders promptly. The service also includes non-perishable items, enabling shoppers to conveniently access a variety of groceries. Through its innovative logistics and delivery system, Market Kurly aims to enhance the grocery shopping experience by transforming the way food is produced and distributed.

XVERSE

Angel Round in 2021
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.

Hetao101

Series C in 2021
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Kelun Biotech

Funding Round in 2021
Kelun Biotech is an innovative biopharmaceutical company based in China, dedicated to the research, development, production, and commercialization of novel drugs. With over a decade of experience, the company has established itself as a pioneer in the development of antibody-drug conjugates (ADCs). Kelun Biotech adopts a systematic and indication-oriented strategy, focusing on prevalent and challenging cancers as well as other medical conditions affecting large, underserved populations. Its commitment to addressing significant medical needs positions the company as a key player in the global biopharmaceutical landscape.

XAG

Series C in 2021
XAircraft is a multi-rotor design and manufacturing company hailing from China with a global footprint of International Distributors. We specialise in the design and development of all sized multi-rotor equipment for various types of applications which includes model aircraft for the weekend hobbyist through to large-scale professional

Cryofocus Biotech

Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

Innocare

Post in 2021
InnoCare is a biopharmaceutical company based in China, focused on discovering, developing, and commercializing innovative treatments for cancer and autoimmune diseases. The company boasts a skilled scientific team with extensive experience in drug innovation from both the U.S. and China, supported by an accomplished Scientific Advisory Board comprised of experts from prominent universities, hospitals, and the pharmaceutical sector. InnoCare's product pipeline includes several key therapies, such as orelabrutinib, ibrutinib, zanubrutinib, and tafasitamab, targeting hematological tumors, solid tumors, and autoimmune disorders. The company is also dedicated to addressing autoimmune diseases linked to abnormal B-cell or T-cell functions, positioning itself as a leader in advancing medical treatments and tackling complex health challenges.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Lalamove

Series F in 2021
Originally known as EasyVan, Lalamove was launched to satisfy a specific logistical need - van hire. Started in Hong Kong in December 2013, Lalamove operates in 21 markets across Asia and Latin America connecting over 7 million customers with a pool of over 700,000 driver-partners. The Lalamove way has revolutionized old van hiring call centers to being so streamlined, customers and drivers match with each other within 12 seconds. Local deliveries are fulfilled at a breakneck 55 minutes, door-to-door. Providing reliable and quick deliveries for customers, Lalamove also optimises drivers fleet and route to maximise their earning potential.

Targeting One

Series B in 2021
Targeting One is a joint-stock technology firm that creates reagents, software, and other products. It is committed to developing products in the life science and molecular diagnostic enterprise, serving life science, precision medicine, drug development, and health management, by developing molecular diagnostic technologies with multiple indicators, high throughput, automation, pollution prevention, and relatively inexpensive.

Delivery Hero

Post in 2021
Delivery Hero is a global network of online food ordering platforms, operating in 21 countries and partnering with over 73,000 restaurants. The company has a significant presence in various markets, including Germany, the UK, South Korea, and several Latin American countries. With a workforce of more than 1,000 employees, around 400 of whom are based at its headquarters in Berlin, Delivery Hero has established itself as a key player in the food delivery industry. The company has attracted substantial investment, securing $523 million in 2014 from various investors, which has helped it expand its reach and capabilities in the competitive online food delivery market.

Core Medical Technology

Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Immvira

Series C in 2020
Immvira, founded in Shenzhen, China, in May 2015 by a group of prominent professors from various universities, is focused on developing biopharmaceutical technology in the field of immunotherapy. The company specializes in creating oncolytic viruses and vector-type approaches aimed at treating cancer. Its primary product is a genetically engineered Oncolytic Herpes Simplex Virus, which is designed to target metastatic tumors or tumors that are difficult to access by direct injection. By leveraging this innovative technology, Immvira aims to provide more effective treatment solutions for patients suffering from cancer.

Lalamove

Series E in 2020
Originally known as EasyVan, Lalamove was launched to satisfy a specific logistical need - van hire. Started in Hong Kong in December 2013, Lalamove operates in 21 markets across Asia and Latin America connecting over 7 million customers with a pool of over 700,000 driver-partners. The Lalamove way has revolutionized old van hiring call centers to being so streamlined, customers and drivers match with each other within 12 seconds. Local deliveries are fulfilled at a breakneck 55 minutes, door-to-door. Providing reliable and quick deliveries for customers, Lalamove also optimises drivers fleet and route to maximise their earning potential.

DEEPEXI

Series A in 2020
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

MicroPort MedBot

Private Equity Round in 2020
MicroPort MedBot is a leading surgical robot company based in Shanghai, China, specializing in the design, development, and commercialization of intelligent surgical solutions. The company focuses on minimally invasive surgery, utilizing advanced technologies such as smart robotics, intelligent control, and information sensing. Its product portfolio includes 3D electronic laparoscopy systems, laparoscopic surgical robots, and orthopedic surgical robots, all aimed at assisting surgeons in performing complex procedures. While the majority of its revenue is generated from the Chinese market, MicroPort MedBot also serves clients in the United States and Europe.

Yuanfudao

Series G in 2020
Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and large pool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.

JD Logistics

Series B in 2020
JD Logistics, a subsidiary of JD.com, operates as a technology-driven supply chain solutions and logistics service provider in China. Established in 2007, JD Logistics focuses on creating efficient and sustainable logistics solutions, encompassing a wide range of services from warehousing to distribution. The company serves various industries, including fast-moving consumer goods, apparel, home appliances, consumer electronics, automotive, and fresh produce. JD Logistics is committed to formulating and executing tailored supply chain strategies to meet the diverse needs of its clients. Its mission is to become the world's most reliable supply chain infrastructure service provider, leveraging technology to enhance operational efficiency.

Antengene

Series C in 2020
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016, that specializes in the development of innovative therapies for cancer treatment. The company's portfolio includes ATG-010 (selinexor), targeting hematologic malignancies such as multiple myeloma, and ATG-008 (onatasertib), an mTOR kinase inhibitor aimed at treating advanced solid tumors and hematological malignancies. Antengene's pipeline features several investigational products, including ATG-016 (eltanexor), ATG-527 (verdinexor), and ATG-019, along with pre-clinical candidates like ATG-101, a bi-specific antibody, and ATG-012, a KRAS G12C inhibitor. The company is committed to addressing unmet medical needs in Asia through its focus on the discovery, development, and commercialization of first-in-class therapeutics for various types of cancer.

Xpeng Motors

Series C in 2020
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.

BeiGene

Post in 2020
BeiGene, Ltd. is a global biotechnology company founded in 2010, focused on discovering and developing innovative oncology treatments to improve accessibility and affordability for cancer patients worldwide. Headquartered in Beijing, the company operates in the U.S., China, and internationally, employing over 9,200 individuals and housing one of the largest oncology research teams globally. BeiGene's commercial products include BRUKINSA, a BTK inhibitor for blood cancers, and Tislelizumab, an anti-PD-1 antibody, which is under regulatory review in the U.S. and EU for advanced esophageal cancer. The company's extensive pipeline targets various malignancies, including acute myeloid leukemia, multiple myeloma, and solid tumors, with potential to address numerous cancer types. In addition to its product portfolio, BeiGene sponsors initiatives to support the broader needs of oncology patients, such as mental health awareness programs. The company has established collaborations with several biotechnology and pharmaceutical firms to enhance its research and development capabilities.

Narwal Robotics

Series C in 2020
Narwal Robotics, officially known as Yunjing (Narwal) Intelligence Technology (Dongguan) Co., Ltd., specializes in the design, development, and production of intelligent cleaning robots. Founded in 2016 and headquartered in Dongguan, China, with an additional office in Shenzhen, the company targets the high-end consumer market. Its flagship product, the Narwal T10, is a self-cleaning robot designed for automated mopping and floor cleaning, utilizing advanced navigation positioning, map construction, and structural design. This technology allows for efficient unmanned cleaning services, providing consumers with convenience and effective cleaning solutions.

Global Data Solutions

Post in 2020
Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries. It provides colocation, managed hosting, and managed cloud services, as well as consulting services. Global Data Solutions's data centers service customers that primarily operate in the Internet and banking industries in Shanghai and Beijing municipalities; and Jiangsu, Guangdong, Sichuan, and Hebei Provinces. It serves cloud service providers, Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. William Wei Huang founded Global Data Solutions in 2000. It has its headquarters in Shanghai in the People's Republic of China.

Everest Medicines

Series C in 2020
Everest Medicines Limited is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2017. The company focuses on licensing, developing, and commercializing innovative therapies to meet critical unmet medical needs in Greater China and other Asia Pacific markets. Its diverse portfolio includes eight clinical-stage drug candidates aimed at treating various conditions such as oncology, immunology, cardio-renal diseases, and infectious diseases. Everest Medicines aims to partner with innovative global companies to bring transformative pharmaceutical solutions to the Emerging Market, leveraging its expertise in clinical development, regulatory affairs, and business operations. The company's pipeline features several notable candidates, including Nefecon, EVER001, PTX-COVID19-B, and Eravacycline, among others.

Genor BioPharma

Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, founded in 2007. It specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing primarily on oncology, autoimmune diseases, and metabolic disorders. The company aims to address significant unmet medical needs through its pipeline, which includes more than ten products, with several already in clinical development. Notable candidates include GB491, an oral CDK4/6 inhibitor; GB221, a novel HER2 mAb; geptanolimab (GB226); and GB242, an infliximab biosimilar. Genor BioPharma also collaborates strategically with Ascentage Pharma to enhance its research and development efforts.

DEEPEXI

Series A in 2020
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

ASR Microelectronics

Series D in 2020
ASR Microelectronics (Shanghai) Co., Ltd. specializes in the research, development, and manufacturing of semiconductors for mobile intelligent communication terminals and consumer electronics. Founded in 2015 and headquartered in Shanghai Zhangjiang Hi-Tech Park, the company produces a range of products including smartphones, modems, and integrated system-on-chip (SoC) solutions. ASR's offerings support various communication standards, including 2G, 3G, and 4G technologies, and encompass applications in the Internet of Things and navigation systems. The company has established a dedicated research and development team in both the United States and South Korea, focusing on platform development and technical support. In 2017, ASR expanded its capabilities through the acquisition of Marvell's Mobile Business Unit, enhancing its position in the market as a leading baseband provider in China. Major investors include several venture capital firms, highlighting ASR's strong financial backing and commitment to technological innovation in wireless communication chips.

MicroPort CardioFlow

Private Equity Round in 2020
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.

Market Kurly

Series E in 2020
Market Kurly is an online grocery service based in Seoul, South Korea, that specializes in the delivery of fresh and premium food products. Founded in 2014, the platform allows users to order a wide range of items, including vegetables, fruits, meats, dairy, baked goods, and processed foods, all sourced directly from producers. Market Kurly focuses on providing high-quality ingredients and offers next-day delivery, ensuring that customers receive their orders promptly. The service also includes non-perishable items, enabling shoppers to conveniently access a variety of groceries. Through its innovative logistics and delivery system, Market Kurly aims to enhance the grocery shopping experience by transforming the way food is produced and distributed.

Suzhou Ribo Life Science

Series C in 2020
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.

Yuanfudao

Series G in 2020
Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and large pool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.

HeyTea

Series D in 2020
HeyTea is a Chinese tea shop that specializes in cheese-topped tea and fruit tea. In 2012, HEYTEA originated from an alley in the riverside. Originally known as ROYALTEA , the royal tea was completely upgraded to the registered brand HEYTEA.

Ke.com

Series D in 2020
KE Holdings Inc., known as Beike, operates a comprehensive platform for housing transactions and services in China, enhancing the user experience through both online and offline channels. Founded in 2001 and headquartered in Beijing, the company facilitates a range of housing-related transactions, including the sale and rental of existing and new homes, home renovation, and real estate financial solutions. Beike operates through its branded Lianjia stores in major cities like Beijing and Shanghai, while also collaborating with various third-party agencies, including franchise partners. The platform aims to create a high-quality ecosystem for real estate services, supporting over 100,000 property agents and reaching more than 200 million households. Additionally, Beike has expanded its offerings internationally, providing services for Chinese families seeking overseas properties across 11 countries. The company's growth strategy includes plans to cover over 300 cities in China and build a robust network of accredited partners.

eRoad Software

Series C in 2020
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated solution for payroll and employee services, targeting mid-to-large sized enterprises. Its platform supports the entire employee lifecycle, encompassing recruiting, onboarding, payroll, and career development. eRoad Software's focus on real-time smart compensation analysis enhances organizational efficiency by offering insights into human effectiveness and cost management. The platform includes comprehensive capabilities for human resources, payroll, benefits, workforce management, performance management, and talent management, aimed at improving business operations and decision-making.

Gritworld

Series A in 2019
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

Elpiscience Biopharmaceuticals

Series B in 2019
Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

Harmay

Series A in 2019
Harmay is a retailer based in China that specializes in premium cosmetics and beauty products. The company focuses on contemporary fashion and aesthetics, aiming to convey the concept of beauty and an enriched lifestyle. Harmay offers a diverse range of well-known international cosmetics and skincare brands, alongside its own self-developed personal skincare products. By targeting urban dwellers, Harmay provides high-quality makeup and cosmetics that resonate with modern beauty standards.

HuidaGene Therapeutics

Series A in 2019
HuidaGene Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2018. The company specializes in the research and development of gene therapies for single-gene disorders and is expanding its focus to neurodegenerative diseases and vision disorders. HuidaGene employs its proprietary CRISPR-based and AI-driven HG-PRECISE platform to create potentially curative therapies. Among its clinical programs, HuidaGene is advancing HG004 for RPE65-associated retinal disease, HG202 for neovascular age-related macular degeneration, HG204 for MECP2 duplication syndrome, and HG302 for Duchenne muscular dystrophy. Several of these therapies have received orphan drug designations and rare pediatric disease designations from regulatory authorities. In addition to its clinical initiatives, the company is exploring preclinical programs, including HG303 for amyotrophic lateral sclerosis and a CRISPR RNA-editing therapy for Alzheimer’s disease.

Gree Electric Appliances

Post in 2019
Gree Electric Appliances, Inc. of Zhuhai is a leading manufacturer of household appliances and industrial equipment, primarily known for its extensive range of air conditioning products. Established in 1989 and headquartered in Zhuhai, China, the company offers a diverse portfolio that includes residential and commercial air conditioners, air-to-water heat pumps, and various home appliances such as electric fans, heaters, water purifiers, and multi-cookers. Gree has evolved into a technologically advanced industrial production group, focusing on both domestic consumer goods and industrial equipment. The company generates a significant portion of its sales within China, with air conditioning systems accounting for a major share of its revenue. Additionally, Gree has expanded into sectors such as industrial components, photovoltaic equipment, and new energy vehicles, underscoring its commitment to innovation and diversification in the appliance industry.

Kujiale

Series D in 2019
Kujiale is an online information and design platform that offers information and reviews on businesses related to home decoration and furnishing. It was launched by Hang Chen and is operated from Hangzhou, China. Create 3D models, swap textures, and apply them in cutting-edge floor planning software. Visualize in 360-degree views, augmented reality, photo-realistic rendering, or virtual reality.

Hetao101

Series B in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Hetao101

Series B in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Golden Technology

Series B in 2019
Golden Technology is a big data service company based in China that specializes in electronic invoicing solutions powered by blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform that serves various sectors, including grocery retailers, parking lots, and restaurants. This platform offers a range of services, including electronic invoicing, reimbursement processing, record-keeping, and transaction management. By utilizing this technology, Golden Technology provides convenient and cost-effective alternatives to traditional paper-based receipts, streamlining financial processes for businesses and enhancing efficiency in transaction management.

DEEPEXI

Series A in 2019
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

Yatsen Holding

Series C in 2019
Yatsen Holding Limited is a beauty company based in Guangzhou, China, specializing in the development and sale of cosmetics and skincare products. The company operates under several brands, including Perfect Diary, Little Ondine, and Abby’s Choice. It offers a diverse range of products, including color cosmetics, eye makeup, lip makeup, face makeup, skincare, and nail products, as well as makeup tools and accessories. Yatsen has established itself as a leader in the online retail space, with Perfect Diary recognized as the top color cosmetics brand in China shortly after its launch. Founded in 2016, the company has expanded its offerings to include perfumes and beauty devices, and it sells its products through both physical stores and online channels.

Aier Eye Hospital Group

Post in 2019
Aier Eye Hospital Group Co., Ltd. is a prominent provider of eye care services, operating a network of approximately 200 ophthalmic hospitals in mainland China, along with additional facilities in Europe, the United States, and Hong Kong. Established in 2007 and headquartered in Changsha, China, the company specializes in a range of ophthalmic treatments, including myopia surgery, cataract and glaucoma management, pediatric ophthalmology, and corneal diseases. It also offers optometry services and training courses focused on cataract prevention and treatment. Aier Eye Hospital Group is dedicated to delivering high-standard medical care and advancing ophthalmic technology and management practices in the region.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.

Ke.com

Series D in 2019
KE Holdings Inc., known as Beike, operates a comprehensive platform for housing transactions and services in China, enhancing the user experience through both online and offline channels. Founded in 2001 and headquartered in Beijing, the company facilitates a range of housing-related transactions, including the sale and rental of existing and new homes, home renovation, and real estate financial solutions. Beike operates through its branded Lianjia stores in major cities like Beijing and Shanghai, while also collaborating with various third-party agencies, including franchise partners. The platform aims to create a high-quality ecosystem for real estate services, supporting over 100,000 property agents and reaching more than 200 million households. Additionally, Beike has expanded its offerings internationally, providing services for Chinese families seeking overseas properties across 11 countries. The company's growth strategy includes plans to cover over 300 cities in China and build a robust network of accredited partners.

eRoad Software

Series C in 2019
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated solution for payroll and employee services, targeting mid-to-large sized enterprises. Its platform supports the entire employee lifecycle, encompassing recruiting, onboarding, payroll, and career development. eRoad Software's focus on real-time smart compensation analysis enhances organizational efficiency by offering insights into human effectiveness and cost management. The platform includes comprehensive capabilities for human resources, payroll, benefits, workforce management, performance management, and talent management, aimed at improving business operations and decision-making.

Jinxin Fertility

Series F in 2019
Jinxin Fertility Group Limited is a prominent provider of assisted reproductive services (ARS) in China and the United States, established in 2003 and headquartered in Chengdu, China. The company offers a range of treatment options, including artificial insemination with either the husband's sperm or donor sperm, as well as in vitro fertilization (IVF) techniques such as conventional IVF and intracytoplasmic sperm injection (ICSI). In addition to these core services, Jinxin Fertility provides various supportive services, including nutritional guidance, traditional Chinese medicine, and psychological counseling, to enhance the patient experience. The organization operates through several subsidiaries, including Chengdu Xinan and Shenzhen Zhongshan, and has expanded its network to deliver high-quality reproductive health services. Jinxin Fertility primarily derives its revenue from its ARS offerings, along with management and ancillary medical services, with a significant portion of its income coming from the Chinese market.

Yunshuxie

Series B in 2019
Yunshuxie is a provider of comprehensive reading and writing solutions tailored for K-12 students in China. The company operates an online platform that archives and organizes a wide range of Chinese literature, creating a structured curriculum to enhance students' reading and writing skills. By integrating offline classroom experiences with online reading clubs, Yunshuxie delivers a holistic approach to literature education, serving over 2 million students. The platform is designed to facilitate both learning and practice in Chinese literature, ensuring that students have access to systematic and complete educational resources.

DEEPEXI

Seed Round in 2019
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

Huolala

Series D in 2019
Huolala offers logistics services, moving, less-than-truckload, car rental and sales, and after-car services. Founded in 2013 and grown in the Guangdong-Hong Kong-Macao Greater Bay Area.

Lalamove

Series D in 2019
Originally known as EasyVan, Lalamove was launched to satisfy a specific logistical need - van hire. Started in Hong Kong in December 2013, Lalamove operates in 21 markets across Asia and Latin America connecting over 7 million customers with a pool of over 700,000 driver-partners. The Lalamove way has revolutionized old van hiring call centers to being so streamlined, customers and drivers match with each other within 12 seconds. Local deliveries are fulfilled at a breakneck 55 minutes, door-to-door. Providing reliable and quick deliveries for customers, Lalamove also optimises drivers fleet and route to maximise their earning potential.

Hetao101

Series A in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Hetao101

Series A in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Woowa Bros

Series G in 2018
WOOWA BROS (우아한형제들) is a Korean developer of smartphone applications and advertising platforms. Its service portfolio also includes local marketing and web services solutions and products, such as a sports events app and a food delivery app. WOOWA BROS was established in March 2011 in Seoul, Korea.

Elpiscience Biopharmaceuticals

Series A in 2018
Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

eRoad Software

Series B in 2018
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated solution for payroll and employee services, targeting mid-to-large sized enterprises. Its platform supports the entire employee lifecycle, encompassing recruiting, onboarding, payroll, and career development. eRoad Software's focus on real-time smart compensation analysis enhances organizational efficiency by offering insights into human effectiveness and cost management. The platform includes comprehensive capabilities for human resources, payroll, benefits, workforce management, performance management, and talent management, aimed at improving business operations and decision-making.

Jacobio Pharmaceuticals

Series C in 2018
Jacobio Pharmaceuticals, established in 2015 in Beijing, is a clinical-stage biotech company focused on developing innovative drugs to address unmet medical needs in China and internationally. The company aims to become a global leader in providing transformative therapies for serious conditions, including cancer, autoimmune, and infectious diseases. Founded by experienced executives from prominent pharmaceutical companies, Jacobio has quickly built a robust drug research and development team exceeding 100 employees, equipped with comprehensive capabilities covering target discovery, medicinal chemistry, pharmacology, and clinical development. The company boasts a promising pipeline of 8 to 10 drug candidates, with JAB-3068 being the most advanced. This program targets a novel potential for both immunotherapy and targeted therapy and is currently undergoing Phase I clinical trials in the United States, with approvals secured for trials in China.

MyDreamPlus

Series C in 2018
MyDreamPlus is a co-working space startup that offers technological working experience in co-working spaces, integrating space design, smart office management, and community operation. It designs high-quality furniture, smart management systems, and more. The company developed a management system that enables customers to solve office-related problems using their smartphones, including opening a door, booking a meeting room, or sending the WIFI password to guests. Founded in May 2015, MyDreamPlus’ services have grown to more than 20 co-working space locations, mainly located in Beijing, Chengdu, and other big cities. There are over 300 enterprises that have joined MyDreamPlus’s co-working space, 90% of which are mature companies, like COFCO, Chinese TAL Education Group, Airbnb, VIPKID, and so on.

Xpeng Motors

Series B in 2018
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.

Xiangwushuo

Series B in 2018
Xiangwushuo is a Beijing-based company that operates an online platform for the buying and selling of unused items. It facilitates the trading of new and idle goods through a unique marketplace that employs a point system, allowing users to exchange items without the need for actual currency. In addition to individual transactions, Xiangwushuo offers business owners the opportunity to promote and sell their products online, enhancing the platform's functionality as a comprehensive marketplace for both personal and commercial goods.

Newtop100.com

Series A in 2018
Newtop100.com is a media and entertainment company based in Beijing, China, founded in 2016. It specializes in publishing news reports and conducting interviews with leaders in the new economy, focusing on innovative technologies and emerging business models. Through various audio and digital media platforms, Newtop100.com provides in-depth coverage and analysis of over 100 leading companies, allowing clients to explore investment opportunities within this dynamic sector. The company aims to highlight pioneers in different domains of the new economy, facilitating informed decisions for investors and stakeholders alike.

Moretickets

Series C in 2018
Moretickets is an online ticketing company based In Shanghai.

I-Mab Biopharma

Series C in 2018
I-Mab Biopharma is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on discovering, developing, and commercializing innovative biologics aimed at addressing significant unmet medical needs, particularly in the areas of immuno-oncology and immuno-inflammation. Its diverse portfolio includes therapies for multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, ulcerative colitis, and various cancer indications. Key development candidates in its pipeline include Uliledlimab, an antibody targeting solid tumors, along with Ragistomig and Givastomig. I-Mab Biopharma is dedicated to advancing treatments that can significantly impact patient health outcomes.

Hangzhou Just Biotherapeutics

Series B in 2018
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.

Magic Ears

Series A in 2018
Magic Ears is an online teaching platform that offers English language classes specifically designed for children aged 5 to 12 in China. The company employs qualified native English-speaking teachers from America and Europe, utilizing innovative technology to deliver a natural and efficient learning experience. Through live video instruction and the use of authoritative textbooks, Magic Ears enables children to learn English in an engaging and pleasant environment, allowing teachers to focus solely on teaching.

BorderX Lab

Series B in 2018
BorderX Lab Inc. is a technology company based in Sunnyvale, California, that specializes in cross-border e-commerce solutions. Founded in 2014, it operates a demand-side platform that connects merchants from various countries, particularly the US and Europe, directly with Chinese consumers. Its flagship product, The Beyond App, serves as a mobile marketplace that leverages big data and artificial intelligence to enhance the shopping experience for affluent Chinese shoppers. The platform allows these consumers to access products and services from global brands without intermediaries, ensuring authenticity and competitive pricing. By curating advertising content, BorderX Lab helps brands effectively engage with the Chinese market while providing a seamless shopping experience for its users.

CStone Pharmaceuticals

Series B in 2018
CStone Pharmaceuticals is a clinical-stage biotechnology company dedicated to developing and commercializing innovative immuno-oncology and molecularly targeted drugs aimed at addressing significant unmet medical needs in cancer treatment. Founded in 2015 and headquartered in Shanghai, China, the company has established a robust product pipeline that includes several late-stage clinical candidates, such as CS1001, a monoclonal antibody targeting programmed death ligand 1, and CS1003, which targets programmed death receptor. Other notable products include ivosidenib, avapritinib, and pralsetinib, along with a variety of additional investigational drugs for solid tumors and other cancer indications. CStone engages in strategic collaborations, including a licensing agreement with Numab Therapeutics for a tri-specific antibody and a clinical partnership with Bayer HealthCare to assess the efficacy of CS1001 in combination therapies. The company aims to enhance treatment options for cancer patients both in China and globally through its dedicated research and development efforts.

Innovent Biologics

Series E in 2018
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.

Interhouse.cn

Series A in 2018
Beijing Interhouse Technology Co., Ltd. operates as a private company specializing in online-to-offline home improvement services. The firm is located in Beijing, China, and offers a digital platform known as Don Quixote. This platform integrates various aspects of design, construction, and operational delivery, utilizing advanced technologies such as Building Information Modeling (BIM), cloud computing, big data, the Internet of Things (IoT), and artificial intelligence (AI). Through these technologies, Interhouse aims to enhance the efficiency and effectiveness of commercial space development and management.

JD Logistics

Venture Round in 2018
JD Logistics, a subsidiary of JD.com, operates as a technology-driven supply chain solutions and logistics service provider in China. Established in 2007, JD Logistics focuses on creating efficient and sustainable logistics solutions, encompassing a wide range of services from warehousing to distribution. The company serves various industries, including fast-moving consumer goods, apparel, home appliances, consumer electronics, automotive, and fresh produce. JD Logistics is committed to formulating and executing tailored supply chain strategies to meet the diverse needs of its clients. Its mission is to become the world's most reliable supply chain infrastructure service provider, leveraging technology to enhance operational efficiency.

Fapiaoer

Series A in 2018
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.

Golden Technology

Series A in 2018
Golden Technology is a big data service company based in China that specializes in electronic invoicing solutions powered by blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform that serves various sectors, including grocery retailers, parking lots, and restaurants. This platform offers a range of services, including electronic invoicing, reimbursement processing, record-keeping, and transaction management. By utilizing this technology, Golden Technology provides convenient and cost-effective alternatives to traditional paper-based receipts, streamlining financial processes for businesses and enhancing efficiency in transaction management.

ThinkForce

Series A in 2017
ThinkForce is a Shanghai-based artificial intelligence chip maker. It focuses on building intelligent semiconductors with AI algorithms and AI hardware platform. ThinkForce is staffed by a strong technical team to ensure successful integration of technology and industrialization.

Arrail Dental

Series D in 2017
Arrail Dental International Group Co. Ltd. is a prominent dental services provider based in Beijing, China, specializing in a wide range of oral health care services. Established in 1998, the company operates numerous clinics across major cities, including Beijing, Shanghai, Shenzhen, and Guangzhou, among others. Arrail Dental offers comprehensive services such as endodontics, general dentistry, orthodontics, pediatric dentistry, and periodontics, as well as specialized treatments like implants and tooth whitening. In addition to in-person consultations, the company facilitates online appointment scheduling to enhance accessibility for its clients. Arrail Dental aims to provide high-quality dental care and has developed a network of elite dentists to support its operations.

Meituan Bike

Series E in 2017
Meituan Bike (formerly Mobike) is a Chinese fully station-less bicycle-sharing system. It develops mobile apps for users to find and use bicycles to travel anywhere. Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping founded Mobike on January 27, 2015, with its headquarters in Beijing, China. Mobike raised $600 million in Series E funding led by Tencent, bringing the firm's fundraising in 2017 alone to nearly US$1 billion in June 2017. It became worth US$3 billion in the same month. Chinese web company Meituan-Dianping acquired Mobike for US$2.7 billion in April 2018. Parent company Meituan-Dianping announced name change from Mobike to Meituan Bike on January 23, 2019 as part of an ongoing integration.

YITU

Series C in 2017
Yitu Limited is a Chinese company that specializes in the research and development of artificial intelligence solutions, focusing on machine vision, listening, and comprehension. Founded in 2012 and based in Shanghai, Yitu provides AI infrastructure and applications for intelligent city management, healthcare, and business sectors such as finance and retail. Their healthcare solutions include AI technologies for disease clinics, child development evaluations, and integrated medical platforms. Yitu's extensive research encompasses areas like computer vision, natural language understanding, and robotics, aiming to drive innovation across various industries, including security, transportation, and healthcare. The company is committed to advancing AI technology to create safer, faster, and healthier environments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.